<PAGE>
OMB APPROVAL
OMB Number: 3235-0145
Expires: August 31, 1995
Estimated average burden
hours per response....14.90
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 8)*
CONTINENTAL MEDICAL SYSTEMS, INC.
- --------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK
- --------------------------------------------------------------------------------
(Title of Class of Securities)
211-642-10-3
----------------------
(CUSIP Number)
Check the following box if a fee is being paid with this statement [ ]. (A fee
is not required only if the filing person: (1) has a previous statement on
file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1: and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7).
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 13 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
<PAGE>
- ------------------------ ---------------------
CUSIP NO. 211-642-10-3 13G PAGE 2 OF 8 PAGES
- ------------------------ ---------------------
- ------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Robert A. Ortenzio
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
2 (a) [X]
(b) [_]
- ------------------------------------------------------------------------------
SEC USE ONLY
3
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
United States of America
- ------------------------------------------------------------------------------
SOLE VOTING POWER
5
NUMBER OF 808,482 (includes options for 476,175 shares)
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 6
1,847,500
OWNED BY
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
7
REPORTING 808,482 (includes options for 476,175 shares)
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 8
1,847,500
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
2,652,482 (includes options for 476,175 shares)
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
10
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
11
6.8%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON*
12
IN
- ------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
Page 2 of 8 pages
<PAGE>
- ------------------------ ---------------------
CUSIP NO. 211-642-10-3 13G PAGE 3 OF 8 PAGES
- ------------------------ ---------------------
- ------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
ROCCO A. ORTENZIO
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
2 (a) [X]
(b) [_]
- ------------------------------------------------------------------------------
SEC USE ONLY
3
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
UNITED STATES OF AMERICA
- ------------------------------------------------------------------------------
SOLE VOTING POWER
5
NUMBER OF 2,169,815 (includes 1,002,500 options and a
conversion right to acquire 233,644
shares)
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 6
2,174,261
OWNED BY
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
7
REPORTING 2,169,815 (includes 1,002,500 options and a
conversion right to acquire 233,644
PERSON shares)
WITH -----------------------------------------------------------
SHARED DISPOSITIVE POWER
8
2,174,261
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
4,344,076 (includes 1,002,500 options and a conversion right to
acquire 233,644 shares)
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
10
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
11
10.9%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON*
12
IN
- ------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
Page 3 of 8 pages
<PAGE>
Page 4 of 8
SECURITIES AND EXCHANGE COMMISSION
SCHEDULE 13G
Item 1(a). Name of Issuer:
Continental Medical Systems, Inc.
Item 1(b). Address of Issuer's Principal Executive Offices:
600 Wilson Lane, Mechanicsburg, Pennsylvania 17055
Item 2(a). Name of Person Filing:
Robert A. Ortenzio
Rocco A. Ortenzio
Item 2(b). Address of Principal Business Offices:
Robert A. Ortenzio
600 Wilson Lane, Mechanicsburg, PA 17055
Rocco A. Ortenzio
600 Wilson Lane, Mechanicsburg, PA 17055
Item 2(c). Citizenship:
United States of America (all reporting individuals)
Item 2(d). CUSIP Number:
211-642-10-3
Item 3. If this statement is filed pursuant to Rules 13d-1(b) or
13d-2(b), check whether the person filing is a:
(NOT APPLICABLE)
<PAGE>
Page 5 of 8 pages
Item 4. Ownership:
Robert A. Ortenzio
(a) 2,652,482 (includes options for 476,175 shares)
(b) 6.8%
(c)(i) 808,482 (includes options for 476,175 shares)
(c)(ii) 1,847,500
(c)(iii) 808,482 (includes options for 476,175 shares)
(c)(iv) 1,847,500
Rocco A. Ortenzio
(a) 4,344,076 (includes 1,002,500 options and a conversion
right to acquire 233,644 shares)
(b) 10.9%
(c)(i) 2,169,815 (includes 1,002,500 options and a conversion
right to acquire 233,644 shares)
(c)(ii) 2,174,261
(c)(iii) 2,169,815 (includes 1,002,500 options and a conversion
right to acquire 233,644 shares)
(c)(iv) 2,174,261
Item 5. Ownership of Five Percent or Less of a Class.
(NOT APPLICABLE)
<PAGE>
Page 6 of 8 pages
Item 6. Ownership of More than Five Percent on Behalf of Another Person
See Item 8 with respect to Healthcare Investors, Inc. and Raymond C.
Grandon.
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the Parent Holding Company.
(NOT APPLICABLE)
Item 8. Identification and Classification of Members of the Group.
Robert A. Ortenzio and Rocco A. Ortenzio are the directors, and
Rocco A. Ortenzio is the majority stockholder, of Liberty Investors,
Inc., which is the owner of record of 1,847,500 shares (4.8%) of the
Issuer's common stock; as such, they share power to direct the vote and
disposition of 1,847,500 shares.
Rocco A. Ortenzio is the owner of record of 933,671 shares of the
issuer's common stock, has exercisable options (within 60 days) to
purchase up to 1,002,500 shares and has a currently exercisable
conversion right to purchase 233,644 shares under a 7-3/4% convertible
subordinated debenture due May 1, 2012. Accordingly, Mr. Ortenzio has
sole power to direct the vote and disposition of 2,169,815 shares.
Rocco A. Ortenzio and Raymond C. Grandon are the directors,
and Rocco A. Ortenzio is the majority stockholder, of Healthcare
Investors, Inc., which is the owner of record of 326,761 shares (less
than 1%) of the Issuer's common stock; as such, they share power to
direct the vote and disposition of the 326,761 shares.
Robert A. Ortenzio is the owner of record of 328,807 shares of
Issuer's common stock, is the owner of record of 3,500 shares as
custodian for the benefit of his children under the UGMAPA Act and has
exercisable options (within 60 days) to purchase up to 476,175 shares.
Accordingly, Mr. Ortenzio has sole power to direct the vote and
disposition of 808,482 shares.
Item 9. Notice of Dissolution of Group.
(NOT APPLICABLE)
Item 10. Certification
(NOT APPLICABLE)
<PAGE>
Page 7 of 8 pages
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 10, 1995
/s/ Robert A. Ortenzio
--------------------------------
Robert A. Ortenzio
<PAGE>
Page 8 of 8 pages
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 10, 1995
/s/ Rocco A. Ortenzio
--------------------------------
Rocco A. Ortenzio
